16 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s
8-K
EX-99.2
fv6oca qqm
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
DEF 14A
yr8et8 9jhdj5l3
30 Apr 19
Definitive proxy
4:04pm
10-K
0y36u5 2gqd9edr
22 Mar 19
Annual report
4:45pm
424B4
u00r6fo
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
cal0hzge42kz
23 Jan 19
IPO registration (amended)
4:39pm
S-1
8v10fxm plktnlxic7
21 Dec 18
IPO registration
4:39pm
DRS/A
ltpk2w266ett
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
d311 06wrvsf9
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next